


编号 10 (2018)
- 年: 2018
- 文章: 13
- URL: https://journals.eco-vector.com/2073-4034/issue/view/7077
Articles
NOVOSTI MEDITsINY
Pharmateca. 2018;(10):4-5



MALADAPTIVE NEUROPLASTICITY
摘要
The article deals with the mechanisms of neuroplasticity, the final outcome of which is a negative result (maladaptive neuroplasticity). By the example of post-stroke motor disorders, its causes are analyzed. The significance of activation of the contralesional cerebral hemisphere, is discussed; although it facilitates the process of restoration of lost functions, it can, however, adversely affect the degree of paresis restoration due to the formation of a pathological motor pattern. The mechanism of transscollosal inhibition also plays a role by the slowing down recovery in the affected area. The maladaptive effect of neuroplasticity is also discussed in the context of sensory disturbances of central origin. The structural and functional bases of cross-modal neuroplasticity are considered in detail. It is emphasized that for violations in one of the sensory modalities, created cross-modal system can have a maladaptive effect due to differences from the existing reality, adversely affecting the unimpaired sensory functions and hindering the processes of optimal recovery. It is noted that such maladaptive manifestations are less pronounced in children. It is concluded that the mechanisms of maladaptive neuroplasticity are heterogeneous. In any case, however, they must be taken into account when planning rehabilitation measures.
Pharmateca. 2018;(10):6-11



ACUTE DISSEMINATED ENCEPHALOMYELITIS IN CHILDREN (LITERATURE REVIEW)
摘要
Acute disseminated encephalomyelitis (ADEM) is an immuno-mediated demyelinating disease of the central nervous system, clinically characterized by new debut multifocal neurological symptoms in combination with multiple foci of demyelination in neuroimaging. ADEM in the classical manifestation is considered a postinfectious monophasic disease, and children are more prone to this disease. The review summarizes the latest literature data on epidemiology, clinical picture, diagnosis, treatment and prognosis of ADEM in children.
Pharmateca. 2018;(10):12-19



ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH ARTERIAL HYPERTENSION AND THE POTENTIALS FOR ITS CORRECTION (LITERATURE REVIEW)
摘要
To date, cardiovascular diseases in patients with rheumatoid arthritis (RA) remains the leading cause of death. the presence of arterial hypertension (AH) contributes significantly to this fact. The presented literature review discusses the problem of the arterial stiffness in RA patients with AH. Pathogenetic mechanisms of the influence of both the AH itself and the activity of the immune-inflammatory process on the condition of the arterial wall and the development of its stiffness in RA are considered. Possible ways or correction of high arterial stiffness (arterial rigidity) in RA patients with AH are analyzed.
Pharmateca. 2018;(10):20-25



VARIANTS OF CELL DEATH AND THEIR BIOCHEMICAL MARKERS
摘要
The article presents modern ideas about various variants of cell death with indication of damage biomarkers participating in these processes. Biomarkers substantially help in clinical studies conducted in the early stages of diseases, and can be much more reliable and economical tools than conventional neurological methods of examination. Thus, these biomarkers will significantly reduce the risks and costs associated with both clinical trials and ultimately with the treatment and management of patients.
Pharmateca. 2018;(10):26-29



POSTHYPOXIC ENCEPHALOPATHY IN PATIENTS AFTER CARDIOSURGICAL INTERVENTIONS: PREVENTION STRATEGIES AND NEUROPROTECTION (LITERATURE REVIEW)
摘要
Posthypoxic encephalopathy is a kind of transient or persistent cerebral dysfunction resulting from a damaging effect of hypoxia on the brain. Symptom complexes presented with neurological, neuropsychological and mental disorders are characterized by high prevalence after cardiosurgical interventions. The article provides information on the methods of prevention of cerebral complications developing on the background of cardiosurgical interventions. The most common non-pharmacological strategy is based on reducing the adverse effects of such risk factors as cerebral hypoperfusion, nonpulsatile blood flow, microembolism, and includes an individual approach to the reduction of operational stress by optimizing intervention techniques. The advantages and disadvantages of local hypothermia, hyperbaric oxygenation, and other methods are analyzed. Information on the influence of the method of drug neuroprotection with the use of drugs of neurometabolic, antihypoxic, nootropic actions, as well as preparations of other pharmacological groups on the prevalence and severity of postoperative cerebral dysfunction is summarized. Aspects that need further clarification are demonstrated.
Pharmateca. 2018;(10):30-35



DIAGNOSIS AND TREATMENT OF THE GUILLAIN-BARRE SYNDROME IN CHILDREN: EXPERT'S OPINION
摘要
The article considers the diagnosis and treatment of the main clinical variants of Guillain-Barre syndrome (GBS) in children - acute inflammatory demyelinating polyneuropathy, acute motor axonal neuropathy, and acute motor-sensory axonal neuropathy. The emphasis is placed on the clinical manifestations of GBS in childhood, the features of motor and sensory disorders, the importance of distinguishing three timeframes of the disease; the additional necessary diagnostic approaches (cerebrospinal fluid analysis and electromyography) are described. From modern positions, pathogenetic methods of treatment are considered - immunotherapy with intravenous standard human immunoglobulin (IVIG) and plasmapheresis. The advantages of therapy with 10% IVIG are presented: high clinical efficacy, rapid onset of action, good tolerability, multicomponent mechanism of action with directed points of application, possibility of use in patients of different age groups - from infant to adult patient). A short transcript and a resolution of the Roundtable «Organization of medical care for children with Guillain-Barre syndrome», which was held on June 8, 2018 in St. Petersburg in the framework of the VIII Baltic Congress on Pediatric Neurology, is also presented.
Pharmateca. 2018;(10):36-42



RELATIONSHIP BETWEEN THYROID STATUS AND PARAMETERS OF DAILY BLOOD PRESSURE MONITORING IN PATIENTS WITH ARTERIAL HYPERTENSION
摘要
Background. Arterial hypertension (AH) is one of the most important and common risk factors for cardiovascular complications. According to the data of a number of studies, various disorders of the thyroid gland function have an impact on the cardiovascular system. Objective. Evaluation of the relationship between thyroid status parameters and the blood pressure (BP) level in persons with AH. Methods. 180 patients with essential AH aged 53.1±9.5 years were examined. Patients underwent thyroid status examination and 24-hour BP monitoring. Results. A direct correlation of thyroid-stimulating hormone level with average daily systolic (SBP) and diastolic blood pressure (DBP), mean BP and with a degree of nocturnal BP decrease (DNBPD) was revealed; inverse correlation of free T3 with average daily SBP, DBP, with mean BP, and direct correlation - with DNBPD were established. Direct correlation of free Т4 and DNBPD was noted. Conclusion. The revealed correlations of the thyroid status parameters, in particular TSH, with the 24-hour BPM datA suggest their participation in the regulation of vascular tone through influence on pressor and depressor mechanisms.
Pharmateca. 2018;(10):43-45



EXPANSION OF INDICATIONS FOR BOTULINUM TOXIN TYPE A PREPARATION (ABOBOTULINUMTOXIN A): THE OPTIMAL APPROACH TO THE SELECTION OF TARGETED MUSCLES AND CALCULATION OF DOSES WITH THE SPASTIC FORMS OF INFANTILE CEREBRAL PALSY
摘要
The article deals with the problem of a multilevel approach to injection of botulinum toxin type A (BTA) preparations to correct spasticity in infantile cerebral palsy (ICP). Through the example of Abobotulinumtoxin A, for which extended indications for use in ICP patients have been obtained in 2017, an optimal approach to the choice of targeted muscles, the calculation of the total dose per procedure and dose for each muscle and injection site, are discussed, as well as the need for repeated injections, the optimal intervals between injections and other aspects, taking into account the child body weight, the degree of spasticity, and the level of development of motor skills. Also, the article presents two clinical observations as examples of determining indications for injecting Abobotulinumtoxin A and choosing the optimal scheme.
Pharmateca. 2018;(10):46-51



CAN SYSTEMIC SKLERODERMIA BE A REASON FOR DEVELOPMENT OF THE STROKE? ANALYSIS OF CLINICAL OBSERVATION
摘要
Background. Systemic scleroderma (SS) is one of the rarest forms of collagenosis, and as many researchers note, primary damage to the central nervous system is much less likely with this disease. In the literature, cases of development of stroke and transient ischemic attacks in patients with SS are usually represented by single observations. However, with the use of modern methods of neuroimaging, the frequency of detection of individuals who have had a stroke against the background of the SS may be significantly higher. Description of the clinical case. The clinical observation of 66-year-old SS patient with ischemic stroke developed against the background of the rapidly progressing course of SS is presented. This case reflects the complexity of diagnosis and treatment in the pre-stroke period with the combination of SS and peripheral vascular disease, as well as difficulties and interpretation of the causes of stroke in such patients. Conclusion. After discussing the presented observation at the pathoanatomical conference, the causal relationship between the SS and the developed multifocal cerebral infarction was confirmed, the pathogenetic variant of ischemic stroke was reviewed: the atherothrombotic subtype was replaced by the «other established etiology» according to the TOAST classification.
Pharmateca. 2018;(10):52-56



CASE OF SUCCESSFUL RECANALIZATION IN ISCHEMIC STROKE PATIENT WITH COMBINED APPLICATION OF INTRAVENOUS THROMBOLYTIC THERAPY AND THROMBEXTRACTION
摘要
Background. Ischemic stroke occupies a leading position among the topical problems of modern medicine due to the high incidence of the disease, as well as a large percentage of disability and mortality. In recent years, intravenous thrombolytic therapy has become a part of the routine methods of treating cerebral stroke with an annual increase in the absolute number of procedures performed in the Russian Federation. At the present time, mechanical thromboextraction is an actively developing field of treatment of ischemic stroke. Description of the clinical case. This clinical observation describes a patient with ischemic stroke in the right middle cerebral artery territory admitted to the hospital at an early stage from the onset of the disease, who underwent the procedure of combined reperfusion therapy with a good clinical and angiographic effect, as well as an evaluation of the long-term results. Conclusion. The presented clinical observation demonstrates the high efficacy and safety of the combination of intravenous thrombolytic therapy and mechanical thromboextraction.
Pharmateca. 2018;(10):57-64



CLINICAL CASE OF SEVERE MYOCARDIAL DAMAGE IN A PATIENT WITH GIPOPITUITARISM
摘要
Background. Hypopituitarism - HP (pituitary insufficiency) is a disease caused by loss of function of tropic hormones (tropins) of the anterior lobe of the pituitary gland and manifested by a deficiency in the function of the peripheral endocrine glands. There are the following types of HP: isolated - reducing the secretion of one tropic hormone; partial - combined loss of function of several tropic hormones; and total (panhypopituitarism) and hypothalamic-pituitary insufficiency - a combination of HP and diabetes insipidus. Among the main causes of HP special mention should go to adenomas and tumors of the pituitary gland and hypothalamus or other parts of the central nervous system, congenital pituitary aplasia, sarcoidosis, tuberculosis, syphilis, inflammatory brain diseases, vascular disorders in the arteries supplying the pituitary gland and the hypothalamus. Description of the clinical case. The article presents a clinical observation of a patient with myocardial damage (probable infectious myocarditis) and HP. Conclusion. The lack of literature data and, accordingly, the lack of clinical experience in the management of such patients make this case unique.
Pharmateca. 2018;(10):65-70



ST-ELEVATED MYOCARDIAL INFARCTION: MODERN APPROACHES TO THE MANAGEMENT OF PATIENTS
摘要
In recent years, an active evaluation of various aspects of the pathogenesis, diagnosis and treatment of acute coronary syndrome has continued. Approaches to the management of such patients are constantly refined and improved, which is reflected in updated versions of clinical guidelines prepared by various professional societies. The purpose of this message is to remind modern principles of management of patients with acute coronary syndrome with persistent ST segment elevation on the electrocardiogram to a wide range of practitioners. It is based on the Russian Society of Specialists in Emergency Cardiology recommendations “Diagnosis and treatment of patients with acute myocardial infarction with ST segment elevation on the electrocardiogram", which appeared in 2014, as well as updated versions of the European Society of Cardiology recommendations on the treatment of ST-elevated myocardial infarction (published in September 2017), myocardial revascularization (published in September 2018) and the 4th universal definition of myocardial infarction, presented in September 2018.
Pharmateca. 2018;(10):71-87


